Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Canadian approval for Viramune announced

Sep. 18, 1998

Boston Biomedica's newest anti-HIV candidates receive patent protection in U.S.

Sep. 15, 1998

Lodensine cleared for phase II trials in HIV patients

Sep. 14, 1998

Gilead announces new clinical trials with GS-1278

Sep. 8, 1998

UC-781: stability in gel formulation, anti-HIV activity

Sep. 8, 1998

Fortovase approved in Europe

Sep. 3, 1998

AnorMED initiates phase I clinical trial of AMD-3100

Sep. 2, 1998

Positive results reported from clinical trial of Remune

Sep. 2, 1998

Dual-action anti-HIV and spermicidal compounds reported by Hughes Institute

Aug. 31, 1998

FDA grants first approval for an antisense drug

Aug. 31, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.